Adalimumab/infliximabPsoriasis and dspnoea: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1593卷 / 1期

关键词：

D O I：

10.1007/s40278-016-15661-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[31] Etanercept/infliximabPsoriasis: 6 case reports
Reactions Weekly, 2007, 1139 (1) : 12 - 12
[32] Etanercept/infliximabPsoriasis: 3 case reports
Reactions Weekly, 2007, 1160 (1) : 18 - 18
[33] Etanercept/infliximabPsoriasis: 4 case reports
Reactions Weekly, 2010, 1319 (1) : 23 - 23
[34] Adalimumab/infliximabHyperhidrosis: 2 case reports
Reactions Weekly, 2016, 1583 (1) : 39 - 39
[35] Adalimumab/infliximabTuberculosis: 2 case reports
Reactions Weekly, 2021, 1846 (1) : 14 - 14
[36] Adalimumab/etanerceptScabies: 2 case reports
Reactions Weekly, 2015, 1546 (1) : 17 - 17
[37] Adalimumab/infliximabLupus: 2 case reports
Reactions Weekly, 2011, 1361 (1) : 5 - 5
[38] Adalimumab/infliximabDermatomycoses: 2 case reports
Reactions Weekly, 2012, 1390 (1) : 6 - 6
[39] Adalimumab/etanerceptSarcoidosis?: 2 case reports
Reactions Weekly, 2010, 1290 (1) : 5 - 5
[40] Adalimumab/etanerceptTuberculosis: 2 case reports
Reactions Weekly, 2013, 1434 (1) : 5 - 5

← 1 2 3 4 5 →